// App-Quantinova.ai

: Highly Comprehensive Genomic Testing for CLL: WGS, One Key to CLL Patient Stratification

Researchers

Presenter

  • Kate E Ridout

Principal Investigators

  • Doriane Cavalieri

  • Jennifer Becq

  • Miao He

  • Ruth Clifford

  • Niamh Appleby

  • Reem Alsolami

  • Adam Burns

  • Melanie Oates

  • Basile Stamatopoulos

  • Samantha Knight

  • Alona Sosinsky

  • Pavlos Antoniou

  • Mark Ross

  • David Bentley

  • Andrew Pettitt

  • Peter Hillmen

  • Mark Caulfield

  • Anna Schuh

Medical Centers

  • Department of Oncology, University of Oxford, Oxford, United Kingdom

  • Oxford Molecular Diagnostics Centre, University of Oxford, Radcliffe Department of Medicine, Oxford, United Kingdom

  • Hematologie Clinique Adulte et Therapie Cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand, France

  • Illumina, Chesterford, United Kingdom

  • National Institute for Health Research Biomedical Research Centre, University of Oxford, Oxford, United Kingdom

  • Department of Oncology, University of Oxford, Oxford, United Kingdom

  • Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom

  • University of Liverpool, Liverpool, United Kingdom

  • Laboratory of Clinical Cell Therapy,Institut Jules Bordet, ULB,Brussels,Belgium

  • National Institute for Health Research Biomedical Research Centre, University of Oxford, Oxford, United Kingdom

  • Genomics England, London, United Kingdom

  • Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom

  • St. James's University Hospital, Leeds, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

Locations

  • United Kingdom

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved